Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             321 results found
no title author magazine year volume issue page(s) type
1 Abnormal cerebro-vascular autoregulation in panic disorder 1990
 27 9S p. 164-
1 p.
 article
2 Abnormal cortical neural networks in major depression and alzheimer's disease: Specificity and relations to clinical state 1990
 27 9S p. 41-
1 p.
 article
3 Abnormal EEG sleep antedates the onset of depression 1990
 27 9S p. 93-
1 p.
 article
4 A calcium channel antagonist enhances ethanol's antiseizure efficacy 1990
 27 9S p. 69-
1 p.
 article
5 A clock in the brain: The suprachiasmatic, hypothalamic nucleus 1990
 27 9S p. 135-
1 p.
 article
6 Acute methylphenidate challenge but not d-amphetamine predicts antidepressant effects of trazadone 1990
 27 9S p. 83-
1 p.
 article
7 Adolescent grief post-parental death 1990
 27 9S p. 174-175
2 p.
 article
8 A double-blind, placebo-controlled study of captopril in the treatment of major depression 1990
 27 9S p. 138-139
2 p.
 article
9 A GABAergic hypothesis of mood disorder 1990
 27 9S p. 145-
1 p.
 article
10 Age of onset and clinical severity in Alzheimer's disease: Neuropathologic and neurochemical correlates 1990
 27 9S p. 43-
1 p.
 article
11 Agonistic and antagonistic interactions of dopamine-uptake blockers in the human frontal cortex 1990
 27 9S p. 82-
1 p.
 article
12 A longitudinal evaluation of dexamethasone pharmacokinetics in depressed patients and normal controls 1990
 27 9S p. 170-
1 p.
 article
13 Alterations of pineal alpha1-adrenergic receptors in suicides and chronic undifferentiated schizophrenic patients 1990
 27 9S p. 111-112
2 p.
 article
14 Altered relationship of plasma FFA and DBH activity in schizophrenia 1990
 27 9S p. 119-120
2 p.
 article
15 Alternative agents in the treatment of manic depression: Focus on cycle frequency, duration, and amplitude 1990
 27 9S p. 145-
1 p.
 article
16 Alzheimer's disease polysomes which show reduced protein synthetic activity contain ribosomes that exhibit no functional or structural abnormalities 1990
 27 9S p. 125-
1 p.
 article
17 Alzheimer's neuropathology in brains of Schizophrenic patients 1990
 27 9S p. 44-
1 p.
 article
18 A model of therapeutic lag 1990
 27 9S p. 157-
1 p.
 article
19 Anticonvulsants: An effective treatment for mania 1990
 27 9S p. 161-
1 p.
 article
20 Antipsychotic efficacy of sigma-receptor antagonists 1990
 27 9S p. 68-
1 p.
 article
21 Apomorphine effects on brain metabolism in neuroleptic-naive, first episode schizophrenics and normal controls 1990
 27 9S p. 109-
1 p.
 article
22 Aprosodia in schizophrenia 1990
 27 9S p. 119-
1 p.
 article
23 Are the effects of short-term cognitive therapy short lived? 1990
 27 9S p. 158-
1 p.
 article
24 Are there clinical predictors of ECT response? 1990
 27 9S p. 64-
1 p.
 article
25 A self-rating instrument for tracking both poles of bipolar disorder 1990
 27 9S p. 139-
1 p.
 article
26 Assessing mania in prepubertal children 1990
 27 9S p. 136-
1 p.
 article
27 Associated psychopathology in winter depression 1990
 27 9S p. 153-154
2 p.
 article
28 A study of the seasonal variation of migraine 1990
 27 9S p. 54-
1 p.
 article
29 A ten-year follow-up study of neuroleptic-induced Parkinsonism 1990
 27 9S p. 129-
1 p.
 article
30 A ten-year follow-up study of supersensitivity psychosis 1990
 27 9S p. 110-
1 p.
 article
31 Attention asymmetry in schizophrenia: hemi-neglect or hyper-orienting? 1990
 27 9S p. 108-
1 p.
 article
32 Attenuation of scopolamine-induced cognitive impairments by dextroamphetamine in young normals 1990
 27 9S p. 89-
1 p.
 article
33 A twin study of attentional dysfunction in schizophrenia 1990
 27 9S p. 48-
1 p.
 article
34 Author index to abstracts 1990
 27 9S p. 181-189
9 p.
 article
35 Autoradiographic identification of the D2 receptor in human cortex by ligand binding 1990
 27 9S p. 88-89
2 p.
 article
36 Avoidant personality disorder: Overlap with social phobia and response to pharmacotherapy 1990
 27 9S p. 146-
1 p.
 article
37 Biochemical actions of phototherapy in sad: Relationship to response 1990
 27 9S p. 158-
1 p.
 article
38 Biological Rhythms in psychiatry: Order and disorder Kupfer, David J.
 1990
 27 9S p. iii-iv
nvt p.
 article
39 Biological variables and rhythms in panic disorder 1990
 27 9S p. 162-163
2 p.
 article
40 Brain morphology in eating disorders 1990
 27 9S p. 62-
1 p.
 article
41 Brain MRI subcortical structural changes in late age onset depression 1990
 27 9S p. 61-
1 p.
 article
42 Calendar of program 1990
 27 9S p. 1-40
40 p.
 article
43 Can the organization of somatostatin systems in human neocortex be accurately assessed in autopsy specimens? 1990
 27 9S p. 73-
1 p.
 article
44 Carbamazepine and the kindling hypothesis of PTSD 1990
 27 9S p. 81-
1 p.
 article
45 Cardiac responsivity and information processing in outpatient schizophrenics and their siblings 1990
 27 9S p. 115-
1 p.
 article
46 Central but not peripheral benzodiazepine agonists attenuate clorgyline effect on melatonin snthesis 1990
 27 9S p. 68-
1 p.
 article
47 Cerebral ventricular enlargement in catatonia 1990
 27 9S p. 59-
1 p.
 article
48 Changes in DST status and plasma dexamethasone levels: Relations to clinical response with ECT 1990
 27 9S p. 169-
1 p.
 article
49 Changes in urinary catecholamine output following phototherapy for fall/winter seasonal depression 1990
 27 9S p. 150-
1 p.
 article
50 Changes in urinary tyramine sulfate excretion predict treatment response in depression 1990
 27 9S p. 157-158
2 p.
 article
51 Characterization of cortical dopaminergic stimulation using three-dimensional brain electrical activity mapping in healthy volunteers 1990
 27 9S p. 71-
1 p.
 article
52 Chronic clozapine decreases mesolimbic but not nigrostriatal dopamine release as measured by in-vivo brain microdialysis: Further evidence for depolarization block 1990
 27 9S p. 84-
1 p.
 article
53 Chronic corticosteroid exposure down regulates adrenal steroid receptors in hippocampus and spleen but not pituitary 1990
 27 9S p. 142-
1 p.
 article
54 Circadian MHPG rhythm: Order and disorder 1990
 27 9S p. 100-
1 p.
 article
55 Clinical and biological predictors of treatment response in mania 1990
 27 9S p. 144-
1 p.
 article
56 Clomipramine in childhood and adolescent obsessive compulsive disorder: A multicenter trial 1990
 27 9S p. 172-
1 p.
 article
57 Cloning and characterization of two cDNA's encoding the human D2 receptor 1990
 27 9S p. 79-
1 p.
 article
58 CNS dopamine sulfate concentrations in drug-free schizophrenic and schizoaffective patients 1990
 27 9S p. 110-
1 p.
 article
59 Cognitive functioning in schizophrenic patients with tardive dyskinesia 1990
 27 9S p. 131-
1 p.
 article
60 Cognitive impairment in HIV-infected hemophiliacs 1990
 27 9S p. 80-
1 p.
 article
61 Comparative physiological and behavioral effects of M-CPP and trazodone in older volunteers 1990
 27 9S p. 88-
1 p.
 article
62 Computer molecular modeling of L-phosphoserine to the NMDA receptor 1990
 27 9S p. 76-77
2 p.
 article
63 Control of tardive dyskinesia by clozapine 1990
 27 9S p. 134-
1 p.
 article
64 Correlation between plasma homovanillic acid concentrations and severity of schizophrenic symptoms: A reflection in an independent sample 1990
 27 9S p. 120-
1 p.
 article
65 Correlations between tardive dyskinesia, drug-induced Parkinsonism, and psychiatric symptoms 1990
 27 9S p. 133-
1 p.
 article
66 Cortical atrophy in schizophrenia: Comparison of CT scan and rCBF findings 1990
 27 9S p. 59-
1 p.
 article
67 CSF Beta-endorphin and dynorphin in bulimia 1990
 27 9S p. 159-
1 p.
 article
68 CSF corticotropin releasing (CRF) in patients with anxiety disorders 1990
 27 9S p. 148-
1 p.
 article
69 CSF somatostatin, CRH, and Acth in alcoholics and controls 1990
 27 9S p. 53-
1 p.
 article
70 CSF thyrotropin-releasing hormone (TRH) in patients with anxiety disorders 1990
 27 9S p. 167-
1 p.
 article
71 CSF TRH in alcoholics and normal controls 1990
 27 9S p. 177-
1 p.
 article
72 Cytokines in neurodegenerative disease 1990
 27 9S p. 57-
1 p.
 article
73 Decrease in tardive dyskinesia with progabide, a mixed GABA agonist 1990
 27 9S p. 131-
1 p.
 article
74 Depression, electrooculograms (EOG), and arden ratios: Differential response to light and dark 1990
 27 9S p. 154-
1 p.
 article
75 Detection of age-specific forms of the Alzheimer's amyloid precursor proteins 1990
 27 9S p. 127-
1 p.
 article
76 Development of the circadian timing system 1990
 27 9S p. 179-
1 p.
 article
77 Diagnostic criteria for neuroleptic malignant syndrome (NMS) 1990
 27 9S p. 129-
1 p.
 article
78 Differential effect of development on parvalbumin content of chandelier and basket neurons in primate neocortex 1990
 27 9S p. 73-74
2 p.
 article
79 Differential effects of long-term lithium prophylaxis in three bipolar subgroups 1990
 27 9S p. 138-
1 p.
 article
80 Different topographic effects of neuroleptics on the severity of tardive dyskinesia 1990
 27 9S p. 128-
1 p.
 article
81 Dimensions of psychopathology in schizophrenia: A factor analytic study 1990
 27 9S p. 107-
1 p.
 article
82 Disruption of noradrenergic and neuroendocrine rhythms in depression 1990
 27 9S p. 100-
1 p.
 article
83 Distribution of dopamine D2 receptor mRNA in primate brain: An in-situ hybridization study 1990
 27 9S p. 141-
1 p.
 article
84 Divalproex sodium's antipanic effect in panic disorder: A placebo-controlled study 1990
 27 9S p. 164-165
2 p.
 article
85 Diverse roles of the activin/inhibin family of hormones and growth factors 1990
 27 9S p. 135-
1 p.
 article
86 Dopamine D1 and D2 receptors in striatum and accumbens after eight months of haloperidol treatment in the rat 1990
 27 9S p. 86-
1 p.
 article
87 Dopaminergic dysfunction in schizotypal personality disorder 1990
 27 9S p. 166-167
2 p.
 article
88 Dopaminergic effects of LSD in an animal model of sensorimotor-gating deficits in schizophrenia 1990
 27 9S p. 97-
1 p.
 article
89 Dopamine sensitivity and cocaine abuse: endocrine and behavioral response to apomorphine 1990
 27 9S p. 53-
1 p.
 article
90 DST and anxiety symptoms in children 1990
 27 9S p. 170-171
2 p.
 article
91 Dysthymia and increased suicide risk among adolescent inpatients with major depression 1990
 27 9S p. 173-
1 p.
 article
92 Eating disorders, anxiety, and 5-HT 1990
 27 9S p. 148-
1 p.
 article
93 Editorial Board 1990
 27 9S p. IFC-
1 p.
 article
94 EEG sleep and cognitive therapy in endogenous depression 1990
 27 9S p. 92-
1 p.
 article
95 EEG sleep in cushing's disease 1990
 27 9S p. 56-
1 p.
 article
96 Effect of serial ECT on serum concentration of alpha1-acid glycoprotein and cortisol 1990
 27 9S p. 63-
1 p.
 article
97 Effects of ascertainment bias on the assessment of cumulative risk in relatives in Alzheimer's disease and other late-onset disorder 1990
 27 9S p. 125-
1 p.
 article
98 Effects of chronic alpha-2 antagonism with idazoxan in bipolar depressed patients 1990
 27 9S p. 153-
1 p.
 article
99 Effects of clonidine and placebo infusions upon premenstrual syndrome patients and controls 1990
 27 9S p. 85-
1 p.
 article
100 Effects of clozapine, spiperone, and SCH 23390 in an animal model of sensorimotor-gating deficits in schizophrenia 1990
 27 9S p. 75-
1 p.
 article
101 Effects of premature birth on intelligence, hyperactivity, and academic achievement 1990
 27 9S p. 146-
1 p.
 article
102 Effects of stress in an animal model for post-traumatic stress disorder (PTSD) 1990
 27 9S p. 77-
1 p.
 article
103 Effects of the benzodiazepine antagonist flumazenil on anxiety ratings in panic patients and controls 1990
 27 9S p. 86-
1 p.
 article
104 Electroconvulsive shock and dopamine neurotransmission 1990
 27 9S p. 143-
1 p.
 article
105 Empirical confirmation of an exaggerated startle response in PTSD 1990
 27 9S p. 165-166
2 p.
 article
106 Enhanced photic-driving EEG alpha in clozapine responders 1990
 27 9S p. 70-71
2 p.
 article
107 Environmental excitotoxins and neurodegenerative disorders 1990
 27 9S p. 90-
1 p.
 article
108 Environmental rhythmicity and temporal order in biological systems 1990
 27 9S p. 179-
1 p.
 article
109 Ethanol-like behavioral response in abstinent alcoholics infused with the 5-HT agonist MCPP 1990
 27 9S p. 176-
1 p.
 article
110 Evidence for a chaotic attractor in bipolar affective disorder 1990
 27 9S p. 99-
1 p.
 article
111 Evidence for increased CRF drive in the evening in depressed patients 1990
 27 9S p. 45-
1 p.
 article
112 Evidence that elimination of ovulation and menstrual cyclicity eliminates menstrually-related dysphoria 1990
 27 9S p. 94-95
2 p.
 article
113 Excitatory amino acid concentrations in CSF of patients with Alzheimer's disease 1990
 27 9S p. 91-
1 p.
 article
114 Excitotoxicity: An overview 1990
 27 9S p. 90-
1 p.
 article
115 Expression of bipolar spectrum disorders in brain-injured patients 1990
 27 9S p. 55-56
2 p.
 article
116 Extrapyramidal syndromes decrease in monkeys during repeated D1- and D2-antagonist treatment 1990
 27 9S p. 141-142
2 p.
 article
117 Eye movement dysfunction in schizophrenia spectrum disorders 1990
 27 9S p. 115-
1 p.
 article
118 Eye movement measurements in volunteer subjects with schizoid/schizotypal personality diagnoses 1990
 27 9S p. 166-
1 p.
 article
119 Failure of acutely administered thyrotropin-releasing hormone (TRH) to counteract ethanol-induced behaviors in normal subjects 1990
 27 9S p. 70-
1 p.
 article
120 Fluoxetine in borderline personality disorder 1990
 27 9S p. 165-
1 p.
 article
121 Fluoxetine trial in borderline personality 1990
 27 9S p. 163-164
2 p.
 article
122 Follow-up study of late-onset depression 1990
 27 9S p. 155-156
2 p.
 article
123 Frequency of side effects in adolescents treated with imipramine 1990
 27 9S p. 174-
1 p.
 article
124 Gating of auditory response in schizophrenics and normal controls: Effects of recording site and stimulation interval on the P50 wave 1990
 27 9S p. 114-
1 p.
 article
125 Genetic linkage strategies for bipolar affective disorders 1990
 27 9S p. 151-
1 p.
 article
126 GH response to clonidine as a correlate of impulsive/aggressive behavior in personality disorder 1990
 27 9S p. 167-
1 p.
 article
127 Glabellar tap reflex as a marker of negative schizophrenia 1990
 27 9S p. 103-
1 p.
 article
128 Gliosis of the corpus callosum in schizophrenia: A postmortem study 1990
 27 9S p. 103-
1 p.
 article
129 Glutamate receptors and age-related neurodegenerative disorders 1990
 27 9S p. 91-
1 p.
 article
130 Growth hormone response in schizophrenics versus schizoaffectives 1990
 27 9S p. 114-
1 p.
 article
131 Heart rate and plasma norepinephrine responsivity to orthostatic challenge in patients with panic disorder and healthy controls 1990
 27 9S p. 149-
1 p.
 article
132 High psychic anxiety associated with poorer ECT response in elderly unipolar depressives 1990
 27 9S p. 63-
1 p.
 article
133 Huntington's disease as a model for mood disorders: Clues from neuropathology and neurochemistry 1990
 27 9S p. 57-
1 p.
 article
134 Imipramine in panic disorder dose-response relationships 1990
 27 9S p. 145-146
2 p.
 article
135 Immune function in major depressive disorder: Relation to panic disorder comorbidity 1990
 27 9S p. 95-
1 p.
 article
136 Immunological function in panic disorder patients and controls 1990
 27 9S p. 65-
1 p.
 article
137 Improved diagnosis of schizophrenic spectrum disorders using a modified FHRDC 1990
 27 9S p. 112-
1 p.
 article
138 Increased biosynthesis of beta-amyloid precursor protein in the brains of rats with lesions of the nucleus basalis of Meynert 1990
 27 9S p. 143-
1 p.
 article
139 Increased corpus callosum size in schizophrenia is associated with perinatal complications 1990
 27 9S p. 51-
1 p.
 article
140 Increased norepinephrine release in normals following chronic lithium 1990
 27 9S p. 161-
1 p.
 article
141 Increased phosphorylation of site 1 of synapsin I during Alzheimer's disease 1990
 27 9S p. 126-
1 p.
 article
142 Increased photic-driving EEG alpha in depressed patients compared with normal controls 1990
 27 9S p. 153-
1 p.
 article
143 Increase in cerebral blood flow but not metabolism by adrenergic systems in rat brain 1990
 27 9S p. 77-78
2 p.
 article
144 Independence between neuroleptic-induced Parkinsonism and tardive dyskinesia 1990
 27 9S p. 130-
1 p.
 article
145 Influence of nigrostriatal dopaminergic tone on the biosynthesis of opioid peptides: Neurochemical basis of tardive dyskinesia 1990
 27 9S p. 132-
1 p.
 article
146 Inhibition of pyruvate dehydrogenase complex (PDHC) by antipsychotic drugs 1990
 27 9S p. 103-
1 p.
 article
147 Initial studies on the development of antemortem diagnostic probes for the beta-amyloid protein of Alzheimer's disease 1990
 27 9S p. 123-
1 p.
 article
148 Interaction of cholinergic and glutamatergic transmission in the hippocampus: An in-vitro autoradiographic-receptor analysis 1990
 27 9S p. 67-68
2 p.
 article
149 Interleukin-1 (IL-1) increases flurazepam electroshock seizure protection 1990
 27 9S p. 64-65
2 p.
 article
150 Inverse relationship between genetic loading and winter birth in schizophrenia 1990
 27 9S p. 50-
1 p.
 article
151 In-vitro receptor involvement in idazoxan attenuation of isoproterenol-stimulated cAMP production 1990
 27 9S p. 75-
1 p.
 article
152 In-vivo assessment of pituitary gland size with MRI: Effects of age and sex 1990
 27 9S p. 61-62
2 p.
 article
153 In-vivo evidence that chronic lithium decreases cortical beta-adrenoceptor-stimulated cAMP production 1990
 27 9S p. 160-
1 p.
 article
154 Is tardive dyskinesia associated with lateral ventricular enlargement in schizophrenia? 1990
 27 9S p. 134-
1 p.
 article
155 Lack of asymmetry in serotonin uptake sites in human brain 1990
 27 9S p. 78-
1 p.
 article
156 Lack of efficacy of D-propranolol in neuroleptic-induced akathisia 1990
 27 9S p. 133-
1 p.
 article
157 Language disturbances significantly associated with cognitive and motoric impairments in psychiatrically hospitalized children 1990
 27 9S p. 173-
1 p.
 article
158 Lateralization of 3H-IMI binding in human frontal cortex 1990
 27 9S p. 72-
1 p.
 article
159 Lateralized visual field abnormalities in schizophrenia 1990
 27 9S p. 48-
1 p.
 article
160 Left striato-pallidal hyperactivity and right-sided hemi-neglect: An integrated model of multileveled pathology in schizophrenia 1990
 27 9S p. 109-
1 p.
 article
161 Less-reduced drug metabolite with IV haloperidol (HAL) 1990
 27 9S p. 83-
1 p.
 article
162 Leukoencephalopathy on MR imaging in late-onset schizophrenia 1990
 27 9S p. 102-
1 p.
 article
163 Limbic lobe measurements by MRI in depressives and medical controls 1990
 27 9S p. 60-
1 p.
 article
164 Lipid decreases imhibit acetazolamide plus thiamine (A + T) effects on psychiatric and extrapyramidal symptoms 1990
 27 9S p. 72-73
2 p.
 article
165 Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression 1990
 27 9S p. 137-
1 p.
 article
166 Lithium potentiation of tricyclic antidepressants: Possible mechanisms 1990
 27 9S p. 139-
1 p.
 article
167 Lithium response and VBR in schizophrenia 1990
 27 9S p. 161-162
2 p.
 article
168 Localization of adrenergic receptors and CRH in human hypothalamus 1990
 27 9S p. 76-
1 p.
 article
169 Longitudinal assessment of Alzheimer's disease: Follow-up of over 250 patients from the consortium to establish a registry for AD (CERAD) 1990
 27 9S p. 42-
1 p.
 article
170 Loss history and glucocorticoid challenge in major affective illness 1990
 27 9S p. 156-
1 p.
 article
171 Low-dose bromocriptine in treatment of schizophrenia and tardive dyskinesia 1990
 27 9S p. 98-
1 p.
 article
172 Lymphocyte function in panic disorder 1990
 27 9S p. 66-
1 p.
 article
173 Lymphokine production in schizophrenic patients 1990
 27 9S p. 118-
1 p.
 article
174 Maternal genetic contributions to CSF monoamines in the rhesus macaque 1990
 27 9S p. 71-
1 p.
 article
175 m-CPP infusion in adult children of alcoholics 1990
 27 9S p. 176-
1 p.
 article
176 Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder 1990
 27 9S p. 46-
1 p.
 article
177 Melatonin suppression in unipolar and bipolar mood disorders 1990
 27 9S p. 151-
1 p.
 article
178 Membership requirements and application procedures 1990
 27 9S p. vi-
1 p.
 article
179 Membrane alterations in schizophrenia 1990
 27 9S p. 113-
1 p.
 article
180 Membrane phospholipid alterations observed in Alzheimer's disease are not present in down's syndrome 1990
 27 9S p. 123-124
2 p.
 article
181 Membrane phospholipids in bipolar disorder 1990
 27 9S p. 155-
1 p.
 article
182 Metabolites elevated in Alzheimer's brain bind to specific glutaminergic receptor subtypes 1990
 27 9S p. 41-42
2 p.
 article
183 Methylphenidate (MPT) exacerbates thought disorders in schizophrenics 1990
 27 9S p. 113-
1 p.
 article
184 Modeling the dynamics of human sleep 1990
 27 9S p. 178-179
2 p.
 article
185 Monoamine metabolite interactions in schizophrenia 1990
 27 9S p. 116-
1 p.
 article
186 MRI changes in panic disorder 1990
 27 9S p. 165-
1 p.
 article
187 MRI correlates of neuropsychological performance in schizophrenia 1990
 27 9S p. 109-110
2 p.
 article
188 MRI of the corpus callosum in depression 1990
 27 9S p. 62-
1 p.
 article
189 Muscarinic hyperactivity in schizophrenia: Relationship to positive/negative symptoms 1990
 27 9S p. 96-
1 p.
 article
190 Natural and lymphokine-activated killer cell activities in schizophrenia 1990
 27 9S p. 66-
1 p.
 article
191 Natural killer cell activity in adolescents with major depression 1990
 27 9S p. 172-
1 p.
 article
192 Natural killer cell activity in schizophrenia and schizoaffective disorder 1990
 27 9S p. 65-
1 p.
 article
193 Negative and positive symptoms correlate with postdexamethasone cortisol in unmedicated schizophrenics 1990
 27 9S p. 169-
1 p.
 article
194 Neurochemistry and neuropharmacology of GABAA-receptor system 1990
 27 9S p. 144-
1 p.
 article
195 Neurocognitive basis of visual search abnormalities in hypothetically psychosis-prone young adults 1990
 27 9S p. 171-172
2 p.
 article
196 Neuroendocrine response to serotonergic challenge in depression 1990
 27 9S p. 45-
1 p.
 article
197 Neuroleptic-discontinuation variables as predictors of treatment response in chronic schizophrenic patients 1990
 27 9S p. 87-
1 p.
 article
198 Neuroleptic effects on positive and negative symptoms in acute schizophrenia 1990
 27 9S p. 50-
1 p.
 article
199 Neuroleptic malignant syndrome: The first 1,000 cases 1990
 27 9S p. 132-133
2 p.
 article
200 Neuropsychological performance of psychotic adolescent inpatients 1990
 27 9S p. 175-
1 p.
 article
201 Neuropsychological predictors of treatment response in schizophrenia 1990
 27 9S p. 117-
1 p.
 article
202 NMR spectroscopy detects brain trifluoperazine and fluoxetine 1990
 27 9S p. 96-
1 p.
 article
203 Nocturnal polysomnography in obsessive-compulsive disorder 1990
 27 9S p. 168-
1 p.
 article
204 Nonimpulsive suicidal behavior correlates with low CSF 5-hydroxyindoleacetic acid 1990
 27 9S p. 47-
1 p.
 article
205 Nonserotonergic receptor alterations in suicide demonstrated by autoradiography 1990
 27 9S p. 47-
1 p.
 article
206 Noradrenergic and neuroendocrine responses to clonidine in depression 1990
 27 9S p. 156-
1 p.
 article
207 Norepinephrine and cortisol responses to naturalistic stressors in acute and remitted depression 1990
 27 9S p. 89-
1 p.
 article
208 Nucleus basalis in schizophrenia 1990
 27 9S p. 104-
1 p.
 article
209 2OH-Desipramine and desipramine plasma levels and therapeutic response in major depression 1990
 27 9S p. 159-
1 p.
 article
210 Olfactory identification correlates of hippocampal atrophy in Alzheimer's disease (AD) 1990
 27 9S p. 126-
1 p.
 article
211 Opiates as immunosuppressive and genotoxic agents 1990
 27 9S p. 67-
1 p.
 article
212 Optimal linear weighting of eye tracking, CPT, and backward masking deficits in discriminating schizophrenic patients and normal controls 1990
 27 9S p. 49-
1 p.
 article
213 Oral S-adenosylmethionine is as effective as desipramine in the treatment of depression 1990
 27 9S p. 138-
1 p.
 article
214 Organization and expression of a dopamine D2 receptor gene 1990
 27 9S p. 140-
1 p.
 article
215 Palmomental reflex in schizophrenia 1990
 27 9S p. 116-117
2 p.
 article
216 Parkinson's disease and dopamine-dependent personality traits 1990
 27 9S p. 55-
1 p.
 article
217 Peripheral oxyradical scavenging enzymes in Schizophrenia 1990
 27 9S p. 106-
1 p.
 article
218 Personality dimensions and dopamine 1990
 27 9S p. 70-
1 p.
 article
219 Personality disorders: Alcohol- vs. cocaine-dependent females 1990
 27 9S p. 163-
1 p.
 article
220 Pharmacokinetics of acutely administered haloperidol (HAL) and prolactin-response curve in young and old volunteers 1990
 27 9S p. 105-
1 p.
 article
221 Phase transitions induced by cocaine in rat locomotor behavior revealed by the thermodynamic formalism of dynamical systems 1990
 27 9S p. 84-
1 p.
 article
222 Phosphoinositide turnover and calcium signaling in Alzheimer's fibroblasts 1990
 27 9S p. 122-
1 p.
 article
223 Physostigmine plus clonidine and yohimbine in Alzheimer's disease: Challenge studies 1990
 27 9S p. 127-
1 p.
 article
224 Pilot studies suggest 60% concordance for Alzheimer's disease in MZ twin pairs 1990
 27 9S p. 43-
1 p.
 article
225 Pituitary enlargement in depression 1990
 27 9S p. 155-
1 p.
 article
226 Plasma catecholamine metabolites in geriatric major depression 1990
 27 9S p. 152-153
2 p.
 article
227 Plasma dopamine and prolactin levels in PTSD 1990
 27 9S p. 72-
1 p.
 article
228 Plasma GABA: Stable trait marker for mood disorders? 1990
 27 9S p. 152-
1 p.
 article
229 Plasma melatonin concentrations in panic disorder 1990
 27 9S p. 66-67
2 p.
 article
230 Plasma norepinephrine in chronic schizophrenia 1990
 27 9S p. 114-115
2 p.
 article
231 Platelet 3H-imipramine binding and leukoencephalopathy in geriatric depression 1990
 27 9S p. 124-
1 p.
 article
232 Platelet MAO in borderline personality disorder 1990
 27 9S p. 147-
1 p.
 article
233 Platelet monoamine levels in schizophrenia, mania, depression, and controls 1990
 27 9S p. 111-
1 p.
 article
234 Polysomnography in depression: A state versus trait evaluation 1990
 27 9S p. 93-
1 p.
 article
235 Postural changes in heart rate during imipramine treatment 1990
 27 9S p. 157-
1 p.
 article
236 −3PPP effects on local cerebral glucose utilization in the rat 1990
 27 9S p. 76-
1 p.
 article
237 Prediction of brain volume with a single MRI slice 1990
 27 9S p. 58-
1 p.
 article
238 Predictive validity of double depression in adolescents 1990
 27 9S p. 174-
1 p.
 article
239 Presence of acidophilic neurons in frontal cortex indicative of cellular dysfunction in depression 1990
 27 9S p. 154-
1 p.
 article
240 Profile of current crack addicts 1990
 27 9S p. 52-
1 p.
 article
241 Prolactin response to bromocriptine in methadone maintenance 1990
 27 9S p. 178-
1 p.
 article
242 Prominent activity rhythm disturbances in hospitalized children with affective illness 1990
 27 9S p. 101-
1 p.
 article
243 Prospective study of tardive dyskinesia in the elderly 1990
 27 9S p. 42-
1 p.
 article
244 Psychobiology of suicide in schizophrenia 1990
 27 9S p. 121-
1 p.
 article
245 Psychological and somatic symptom and illness patterns in individuals with self-reported adverse food reactions 1990
 27 9S p. 168-
1 p.
 article
246 Psychotic phasic and deficit enduring subtypes of negative symptoms: Biological markers and relationship to outcome 1990
 27 9S p. 101-102
2 p.
 article
247 P300 topographic changes in outpatient schizophrenics: Relationship to brain pathology 1990
 27 9S p. 61-
1 p.
 article
248 Rates of cerebral glucose metabolism after neuroleptic withdrawal in schizophrenic patients 1990
 27 9S p. 97-98
2 p.
 article
249 Rat locomotor hyperactivity induced by serotonin release 1990
 27 9S p. 74-
1 p.
 article
250 Redistribution of sequestered cerebral iron suggests possible role in neurotransmission 1990
 27 9S p. 78-79
2 p.
 article
251 Reduced haloperidol induces prolactin response in schizophrenic patients 1990
 27 9S p. 106-107
2 p.
 article
252 Regional analysis of gray matter volumes in schizophrenia: An MRI study 1990
 27 9S p. 60-
1 p.
 article
253 Regulation of dopamine D2 receptor mRNA by chronic haloperidol treatment 1990
 27 9S p. 141-
1 p.
 article
254 Regulation of serotonin receptors and serotonin receptor mRNA's: Role of endogenous and exogenous factors 1990
 27 9S p. 142-
1 p.
 article
255 Relations between orienting response nonresponsiveness and smooth pursuit eye movement abnormalities in schizophrenic patients 1990
 27 9S p. 102-
1 p.
 article
256 Relationship between aging and cortisol response to diazepam 1990
 27 9S p. 87-
1 p.
 article
257 Relationship between MRI T2-signal hyperintensities and cognitive impairment after ECT in depressed patients 1990
 27 9S p. 64-
1 p.
 article
258 Relationship between somatostatin and 5-HIAA in Alzheimer's disease and geriatric depression 1990
 27 9S p. 122-123
2 p.
 article
259 Relationship of weight control practices and alcohol use in female psychiatric patients 1990
 27 9S p. 175-176
2 p.
 article
260 Relationships among cebus monkey AEP, behavior, time, and fluphenazine 1990
 27 9S p. 87-88
2 p.
 article
261 Relevance of dopamine transporter binding in the frontal cortex to schizophrenia 1990
 27 9S p. 51-
1 p.
 article
262 REM density changes in schizophrenia due to biperiden 1990
 27 9S p. 108-
1 p.
 article
263 Response to total sleep deprivation in therapy-resistant depression: Clinical and hormonal findings 1990
 27 9S p. 149-150
2 p.
 article
264 Reversible metabolism of haloperidol (HAL) and reduced HAL (RHAL): A hypothesis concerning the therapeutic window effect of HAL treatment 1990
 27 9S p. 80-
1 p.
 article
265 Schizophrenia-like psychosis in Parkinson's disease 1990
 27 9S p. 56-57
2 p.
 article
266 Schizophrenic frontal lobe metabolism stability over time: Test-retest using binary image correspondence 1990
 27 9S p. 112-
1 p.
 article
267 Schizophrenic-like sensorimotor-gating deficits after mesolimbic dopamine (DA) activation in rats 1990
 27 9S p. 74-
1 p.
 article
268 Schizophrenics are attending 1990
 27 9S p. 105-
1 p.
 article
269 Schizotypal symptoms as predictors of attentional dysfunction in relatives of schizophrenics 1990
 27 9S p. 117-
1 p.
 article
270 Seasonal rhythms in behavior: Insights from animal models 1990
 27 9S p. 179-
1 p.
 article
271 Sensorimotor deficits and increased wisconsin card sorting test perseverations in schizophrenia 1990
 27 9S p. 49-
1 p.
 article
272 Separation of chronic marihuana (THC) users from nonusers: A discriminant function analysis using quantitative electroencephalographic variables 1990
 27 9S p. 52-53
2 p.
 article
273 Serotonergic and neuropsychiatric function in impulsive personality disorders 1990
 27 9S p. 163-
1 p.
 article
274 Serotonergic responsivity to m-CPP in OCD patients during clomipramine and fluoxetine treatment 1990
 27 9S p. 81-
1 p.
 article
275 Serum and CSF interleukin-1 in bulimia nervosa 1990
 27 9S p. 147-148
2 p.
 article
276 Sex differences in neurocognition of schizophrenia 1990
 27 9S p. 121-
1 p.
 article
277 Sexual dysfunction and methadone maintenance 1990
 27 9S p. 52-
1 p.
 article
278 Sleep EEG findings in behaviorally disturbed brain-injured patients with sleep complaints 1990
 27 9S p. 55-
1 p.
 article
279 Society information 1990
 27 9S p. vii-xvi
nvt p.
 article
280 Spectral power shifts within the EEG alpha frequency band associated with chronic heavy marihuana (THC) use 1990
 27 9S p. 177-
1 p.
 article
281 Staining intensity of brain iron in patients with schizophrenia: A postmortem study 1990
 27 9S p. 111-
1 p.
 article
282 Statement of purpose 1990
 27 9S p. v-
1 p.
 article
283 Stimulated and spontaneous GH in schizophrenics 1990
 27 9S p. 120-
1 p.
 article
284 Striatal dopamine receptors unaffected by iron deficiency 1990
 27 9S p. 79-
1 p.
 article
285 Subcortical changes in normal aging 1990
 27 9S p. 124-
1 p.
 article
286 Subcortical hyperintensities in elderly subjects with mania 1990
 27 9S p. 162-
1 p.
 article
287 Suicidal behavior in schizophrenia 1990
 27 9S p. 121-122
2 p.
 article
288 Sulcal, medical temporal, and ventricular abnormalities by MRI: Comparing major psychoses 1990
 27 9S p. 59-60
2 p.
 article
289 Sustained hypercortisolemia decreases plasma dexamethasone half-life in rabbits 1990
 27 9S p. 170-
1 p.
 article
290 Systematic genomic mapping of genes for manic-depressive disease: Studies of chromosomes 5 and 11 1990
 27 9S p. 46-47
2 p.
 article
291 Tardive dyskinesia longitudinal follow-up study 1990
 27 9S p. 130-
1 p.
 article
292 Temporal lobe structure in schizophrenia: A controlled multiplanar magnetic resonance (MR) study 1990
 27 9S p. 58-
1 p.
 article
293 Testing the hypothesis that Y-chromosomal haplotype is associated with impulsive behavior 1990
 27 9S p. 69-
1 p.
 article
294 The diversity of autoantibodies in schizophrenic patients and their first-degree relatives: analysis of multiple case families 1990
 27 9S p. 118-
1 p.
 article
295 The dopaminergic innervation of human prefrontal cortex 1990
 27 9S p. 140-
1 p.
 article
296 The effect of age on DST status and plasma dexamethasone concentration in depressed patients 1990
 27 9S p. 45-46
2 p.
 article
297 The effect of L-DOPA on negative symptoms, cognitive performance, and regional cerebral blood flow in schizophrenia 1990
 27 9S p. 118-119
2 p.
 article
298 The effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression 1990
 27 9S p. 152-
1 p.
 article
299 The importance of the plasma dexamethasone “window”: A dose-response study in depressed patients and controls 1990
 27 9S p. 171-
1 p.
 article
300 The NMDA-PCP theory of schizophrenia: Implications of receptor interactions 1990
 27 9S p. 91-92
2 p.
 article
301 The physics and metaphysics of chaos: Is it relevant to biological psychiatry? 1990
 27 9S p. 136-
1 p.
 article
302 The prevalence of tardive dyskinesia (TD) is increased in neuroleptic-treated diabetics 1990
 27 9S p. 98-99
2 p.
 article
303 “Therapeutic window” in schizophrenic patients treated by sulpiride 1990
 27 9S p. 116-
1 p.
 article
304 The relationship between CSF peptides, neurotransmitters, and VBR in depressed patients and normal controls 1990
 27 9S p. 44-
1 p.
 article
305 The relationship between serum haloperidol, smoking, and tardive dyskinesia (TD) 1990
 27 9S p. 128-
1 p.
 article
306 The residual effect of cranial injury on postraumatic stress symptoms over 40 years later 1990
 27 9S p. 54-
1 p.
 article
307 The role of cortisol nonsuppression and life stress in the etiology of young and elderly depressives 1990
 27 9S p. 95-96
2 p.
 article
308 The sleep microarchitecture of depression: A preliminary report 1990
 27 9S p. 94-
1 p.
 article
309 The temperature rhythm is phase-delayed in winter depression 1990
 27 9S p. 99-
1 p.
 article
310 The use of laboratory blood values to confirm reports of alcohol use in inpatient schizophrenics 1990
 27 9S p. 178-
1 p.
 article
311 Time course of psychopathologic and motor TD changes after blind neuroleptic withdrawal 1990
 27 9S p. 132-
1 p.
 article
312 Topographic EEG changes during treatment with lithium (Li), carbamazepine (CBZ), and clomipramine (CMI) 1990
 27 9S p. 160-
1 p.
 article
313 Total sleep deprivation and response to antidepressive medication 1990
 27 9S p. 137-
1 p.
 article
314 Treatment of neuroleptic-induced supersensitivity psychosis with antiepileptic drugs 1990
 27 9S p. 129-130
2 p.
 article
315 TRH-TSH test and DST in major depression and response to antidepressant treatment 1990
 27 9S p. 150-151
2 p.
 article
316 Tryptophan reduces need for medication in aggressive patients 1990
 27 9S p. 147-
1 p.
 article
317 Urinary MHPG and phenelzine treatment 1990
 27 9S p. 85-
1 p.
 article
318 Validity and reliability of a new assessment of impulsive aggressive behaviors for clinical psychopharmacologic trials with 5-HT agents 1990
 27 9S p. 82-
1 p.
 article
319 Ventricle-brain ratio, cognitive function, educational achievement, and premorbid function in schizophrenia 1990
 27 9S p. 107-
1 p.
 article
320 Ventricular to brain ratio and blink rate changes predict clinical response to acute amphetamine challenge in schizophrenia 1990
 27 9S p. 97-
1 p.
 article
321 Wisconsin card sort activated EEG spectra in schizophrenia 1990
 27 9S p. 104-
1 p.
 article
                             321 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands